The right drug at the right dose at the right time. Those goals drive pharmacogenomics how genetics influence a person's response to medications. <\/p>\n
Chemotherapy drugs are more effective when treating certain types of cancers. Codeine offers no pain relief in some patients and in others causes life-threatening reactions, such as respiratory depression. Other individuals experience harmful side effects from statin drugs designed to lower cholesterol levels. Finding the right dose of blood-thinning agents, such as warfarin, can involve a long process of trial and error. <\/p>\n
Some Food and Drug Administration-approved drug labels contain warnings or information about potential adverse event risks, variable responses, drug-action mechanisms or genotype-based drug dosing. Recommendations are based on genomic information about the drug. <\/p>\n
Pharmacogenomics drives greater drug effectiveness, with increased safety and reduced side effects. At Mayo Clinic, drug-gene alerts are part of the electronic medical record system, assisting providers in delivering safer, more effective care. <\/p>\n
Each day, research uncovers new gene variants or novel drug-gene interactions that influence whether a patient may be harmed or helped by a medication. Keeping up to date with complex, new genomic information is a challenging task for clinicians, but decision-support tools and online education helps. <\/p>\n
The Center for Individualized Medicine at Mayo Clinic is adding drug-gene interactions to the patient electronic medical record to alert physicians and pharmacists at the point of care as part of the clinical decision-support system. <\/p>\n
If genomic information exists for a drug-gene interaction, alerts are triggered in the patient's electronic medical record to guide the clinician regarding prescription choices and dosing recommendations. <\/p>\n
A team of physicians, pharmacists, genetic counselors and medical educators provides just-in-time education linked to these pop-up alerts. Online resources provide information about: <\/p>\n
Ongoing discovery and validation of new drug-gene pairs at Mayo Clinic and elsewhere will result in additional alerts being added to the electronic medical record. <\/p>\n
Applied pharmacogenomics resolves patient's lifelong anxiety and depression.<\/p>\n
<\/p>\n
Read more here: The right drug at the right dose at the right time. Those goals drive pharmacogenomics how genetics influence a person's response to medications. Chemotherapy drugs are more effective when treating certain types of cancers Continue reading
\nDrug-Gene Alerts - Mayo Clinic Center for Individualized ...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"